Patent · US Active

Method of treatment using substituted imidazo[1,2B]pyridazine compounds

US9227975B2 · kind B2 · utility

12Cited by
8References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2012
Grant dateJan 5, 2016
Priority date
Expiry dateSep 13, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula Iin which R1, R2, R3, R4, X, Y and n have the meanings given in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.